跳至主要内容
临床试验/NCT02635581
NCT02635581已完成不适用

A DEXA Clinical Study to Evaluate the Osteointegrative Potential of Trabecular Titanium™

Limacorporate S.p.a8 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2008年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
84
试验地点
8
主要终点
The percentage change of the bone mineral density (BMD) around the acetabular cups with DEXA scan

研究概览

简要总结

The purpose of this clinical trial is to evaluate the osteointegrative potential of the Trabecular TitaniumTM and to measure the pattern of changing in bone mineral density (BMD) around an uncemented acetabular cup, manufactured in Trabecular Titanium™ , during 60 months after surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI< 40 kg/m2
  • Indication suitable to the implantation of Delta TT acetabular cup (First implant)
  • Idiopathic osteoarthritis
  • Avascular necrosis
  • Post-traumatic arthritis
  • Presence of sufficient periacetabular bone stock
  • Ability to understand the investigation, cooperate with the investigational procedure and willing to return to the hospital for the required post-operative follow-ups
  • Written informed consent

排除标准

  • Patients found unsuitable for an implantation of Delta TT acetabular cup (Revision)
  • Patients aged 76 or older
  • Haemophilic disease
  • Femur neck fracture
  • Insulin Dependent Diabetes Mellitus (IDDM)
  • Severe kidney failure (grade 4)
  • Not responder Hypo- or Hyperthyroidism
  • Paget's disease
  • Active or suspicious infections
  • Neurosensory deficits or neuromuscular diseases
  • Severe and impairing vascular diseases
  • Known incompatibility or allergy to products materials
  • Woman with pregnancy or childbearing capacity or breast-feeding
  • Subjects already enrolled in other clinical trials

结局指标

主要结局

The percentage change of the bone mineral density (BMD) around the acetabular cups with DEXA scan

时间窗: From baseline to 5 year Follow-up

次要结局

  • Harris Hip Score (HHS)(From baseline to 5 year Follow-up)
  • SF-36 score(From baseline to 5 year Follow-up)

研究者

发起方
Limacorporate S.p.a
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验